Adagio Therapeutics
Adagio is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses.
Rankings by
National Ranking414th
in United States Regional Ranking470th
in North America and Caribbean Global Ranking1129th
worldwide